Trinidad and Tobago vs Uruguay: HIV-positive TB patients on ART (antiretroviral therapy)
Trinidad and Tobago
51.0%
in 2024
Uruguay
39.0%
in 2024
Trinidad and Tobago rank
139th
Uruguay rank
140th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Trinidad and Tobago
- Uruguay
How they compare
Trinidad and Tobago currently reports 51.0% against 39.0% in Uruguay, a difference of 12.0%.
That makes Trinidad and Tobago's figure about 1.3 times Uruguay's.
The two have swapped places 8 times across 19 shared years of data; in 2006 it was Trinidad and Tobago ahead.
Trinidad and Tobago ranks 139th and Uruguay ranks 140th of 144 countries.
Across the 3 decades both report, Trinidad and Tobago averaged higher in 2 and Uruguay in 1.
Head to head by decade
| Decade | Trinidad and Tobago | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.3% | 22.5% | 21.8% | Trinidad and Tobago |
| 2010s | 42.7% | 51.1% | 8.4% | Uruguay |
| 2020s | 81.0% | 37.6% | 43.4% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Trinidad and Tobago or Uruguay?
- Trinidad and Tobago, at 51.0% against 39.0% in Uruguay as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Trinidad and Tobago and Uruguay?
- 12.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Trinidad and Tobago and Uruguay?
- 19 years are reported by both, from 2006 to 2024.
- How do Trinidad and Tobago and Uruguay rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Trinidad and Tobago ranks 139th and Uruguay ranks 140th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.